News & Events

• September 29, 2021
  

  Volumetric MRI-Based Biomarkers in Huntington’s Disease: An Evidentiary Review

  C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based biomarkers in HD.

• November 1, 2018
  

  C-Path, CHDI and CDISC Announce Therapeutic Area User Guide for Huntington’s Disease

  TUCSON, Ariz., NEW YORK and AUSTIN, Texas, November 1, 2018 — The Huntington’s Disease Regulatory Science Consortium (HD-RSC), launched in March 2018 by the Critical Path Institute (C-Path) and CHDI Foundation, today, along with the Clinical Data Interchange Standards Consortium (CDISC), announce the open availability of a newly developed Huntington’s Disease Therapeutic Area User Guide...
• March 28, 2018
  

  C-Path and CHDI launch consortium to accelerate development of Huntington’s disease therapies

        Tucson, AZ, and New York, NY – March 28, 2018 – The Critical Path Institute (C-Path), together with CHDI Foundation, Inc. (CHDI), today announced the official launch of C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC). In addition to these cofounders, the consortium also includes more than 20 different member organizations, including industry partners,...